Cargando…
Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity
BACKGROUND: 3,4-Methylenedioxymethamphetamine (MDMA) produces a neuroinflammatory reaction in rat brain characterized by an increase in interleukin-1 beta (IL-1β) and microglial activation. The CB2 receptor agonist JWH-015 reduces both these changes and partially protects against MDMA-induced neurot...
Autores principales: | Torres, Elisa, Gutierrez-Lopez, Maria D, Mayado, Andrea, Rubio, Ana, O'Shea, Esther, Colado, Maria I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113340/ https://www.ncbi.nlm.nih.gov/pubmed/21595923 http://dx.doi.org/10.1186/1742-2094-8-53 |
Ejemplares similares
-
Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA
por: Mayado, Andrea, et al.
Publicado: (2011) -
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007) -
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)